Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nash

Showing results (541-550 of 609) with videos related to

Pageof 61
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 6, 2020
Revealing hidden genetic diagnoses in the ocular anterior segment disordersAlan Ma, Saira Yousoof, John R Grigg, et al.
The Oncologist|March 12, 2022
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal CancerJin K Kim, Michael R Marco, Campbell S D Roxburgh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Coaltered <i>Ras/B-raf</i> and <i>TP53</i> Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal CancerJashodeep Datta, J Joshua Smith, Walid K Chatila, et al.
JAMA Oncology|January 11, 2019
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant TherapyJ Joshua Smith, Paul Strombom, Oliver S Chow, et al.
Diseases of the Colon and Rectum|January 14, 2025
Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-WaitRoni Y Rosen, Aron P Bercz, Dana M Omer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2020
Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant ChemotherapyAndrea Cercek, Gustavo Dos Santos Fernandes, Campbell S Roxburgh, et al.
Investigative Ophthalmology & Visual Science|April 14, 2026
ABCA4 Versus PRPH2-Associated Retinopathy: Clinical and Electrophysiological FindingsRachael C Heath Jeffery, Jennifer A Thompson, Johnny Lo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and ChemoresistanceIsaac Wasserman, Lik Hang Lee, Shuji Ogino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2024
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapyA Bercz, B K Park, E Pappou, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Pageof 61

Showing results (541-550 of 609) with videos related to

Sort By:
Pageof 61
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 6, 2020
Revealing hidden genetic diagnoses in the ocular anterior segment disordersAlan Ma, Saira Yousoof, John R Grigg, et al.
The Oncologist|March 12, 2022
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal CancerJin K Kim, Michael R Marco, Campbell S D Roxburgh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Coaltered <i>Ras/B-raf</i> and <i>TP53</i> Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal CancerJashodeep Datta, J Joshua Smith, Walid K Chatila, et al.
JAMA Oncology|January 11, 2019
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant TherapyJ Joshua Smith, Paul Strombom, Oliver S Chow, et al.
Diseases of the Colon and Rectum|January 14, 2025
Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-WaitRoni Y Rosen, Aron P Bercz, Dana M Omer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2020
Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant ChemotherapyAndrea Cercek, Gustavo Dos Santos Fernandes, Campbell S Roxburgh, et al.
Investigative Ophthalmology & Visual Science|April 14, 2026
ABCA4 Versus PRPH2-Associated Retinopathy: Clinical and Electrophysiological FindingsRachael C Heath Jeffery, Jennifer A Thompson, Johnny Lo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and ChemoresistanceIsaac Wasserman, Lik Hang Lee, Shuji Ogino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2024
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapyA Bercz, B K Park, E Pappou, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Pageof 61